# Calcipotriol + Betamethasone

## Daivobet ointment 30gm

##### 

| TAH Drug Code      | EDAIV                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Psoriasis vulgaris.                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Dosing             | Psoriasis Apply to the affected area once daily for 4 weeks. After this period, repeated treatment can be initiated under medical supervision. Maximum daily dose: 15 g. Maximum weekly dose: 100 g. Max treated area: 30% of the body surface.                                                                                                                                                                                                  |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Contraindications  | Disorders of Ca metabolism, viral, fungal or bacterial skin infections, parasitic infections, skin manifestations in relation to TB or syphilis, rosacea, acne rosacea, perioral dermatitis, acne vulgaris, skin atrophy, striae atrophicae, fragility of skin veins, ichthyosis, ulcers, wounds, perianal & genital pruritus; guttate, erythrodermic, exfoliative & pustular psoriasis, severe renal insufficiency or severe hepatic disorders. |
| Adverse Effects    | Pruritus, local transient irritation, dermatitis, erythema, aggravation of psoriasis, photosensitivity & hypersensitivity reactions. Dermatologic: Atrophic condition of skin (1.9% ), Pruritus (3.1% to 7.2% ), Psoriasis (1.2 to 3.4% ), Rash, scaly (1.2% ) Neurologic: Headache (2.8% )                                                                                                                                                      |
| Pregnancy          | Compatible – Maternal Benefit >> Embryo-Fetal Risk                                                                                                                                                                                                                                                                                                                                                                                               |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                  |

## Xamiol gel 30gm

##### 

| TAH Drug Code      | EXAM                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Plaque psoriasis:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Dosing             | Apply to the affected area once daily. Recommended treatment period: 4 weeks. After this period, repeated treatment can be initiated under medical supervision. Max daily dose: 15 g. Max weekly dose: 100 g. Max treated area: 30% of body surface.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Contraindications  | Hypersensitivity to calcipotriene, betamethasone, or any component of the formulation; viral (herpes simplex, varicella, vaccinia), fungal or bacterial infection of the skin; parasitic infections; tuberculosis of the skin; syphilitic skin infections; ophthalmic use; calcium metabolism disorders; perioral dermatitis; atrophic skin; striae atrophicae; fragility of skin veins; ichthyosis; acne vulgaris; acne rosacea; rosacea; ulcers; wounds; perianal and genital pruritus; psoriasis (guttate, erythrodermic, exfoliative); severe hepatic disorders; severe renal insufficiency                                                                                                                                             |
| Adverse Effects    | 1% to 10%: Dermatologic: Pruritus (4% to 7%), psoriasis (2% to 3%), erythema (1% to 2%), skin atrophy (<2%), burning sensation of skin (1%), ecchymoses (1%), exfoliative dermatitis (1%), hand dermatosis (1%), skin depigmentation (1%), skin irritation (1%), folliculitis (<1%) <1% (Limited to important or life-threatening): Acneiform eruption, acne vulgaris, application-site pruritus, contact dermatitis, dermatitis, exacerbation of psoriasis, eye irritation, facial edema, HPA-axis suppression, hypercalcemia, hypercalciuria, hyperpigmentation, hypopigmentation, otitis externa, papular rash, psoriasis flare, psoriasis (rebound), pustular psoriasis, pustular rash, skin pain, skin rash, telangiectasia, xeroderma |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

